Quadrant Capital Group’s Innophos Holdings, Inc. IPHS Stock Holding History

Quadrant Capital Group’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,087	Closed	-$97K	–	2364
2019 Q4	$97K	Hold	3,087	–	–	0.01%	996
2019 Q3	$98K	Buy	3,087 +2,321	+303%	+$66.9K	0.02%	887
2019 Q2	$20K	Buy	766 +536	+233%	+$16K	﹤0.01%	1642
2019 Q1	$6K	Buy	230 +97	+73%	+$2.91K	﹤0.01%	1848
2018 Q4	$3K	Buy	+133	New	+$4.04K	﹤0.01%	1837

Other funds holding IPHS

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Quadrant Capital Group's IPHS Position: Q1 2020 in Review

Quadrant Capital Group sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 3,087 shares — an estimated $97K sold.

Quadrant Capital Group first reported a position in IPHS in Q4 2018 and held it in 5 quarters. The position peaked at $98K in Q3 2019. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

Quadrant Capital Group reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Quadrant Capital Group sold 3,087 Innophos Holdings, Inc. shares in Q1 2020, an estimated $97K.
Quadrant Capital Group first reported a position in Innophos Holdings, Inc. in Q4 2018 and held it in 5 quarters.
Quadrant Capital Group's Innophos Holdings, Inc. position peaked at $98K in Q3 2019.
2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on Quadrant Capital Group's 13F filing for Q1 2020, filed 15 May 2020.